This report is based on public company disclosures, filings and announcements reviewed by GSN; figures are as stated by the company and have not been independently verified.

Every technology company with a roadmap eventually has to answer two questions. What is paying for its future now? And when does a customer start paying for it instead? In a new investor presentation filed with US regulators, Quantum Computing Inc. (Nasdaq: QUBT), which calls itself QCi, answers the first one loudly. It is still working on the second.

The pitch

The presentation was filed as Exhibit 99.1 and carries the names of chairman and chief executive Yuping Huang and chief financial officer Christopher Roberts. It is a pitch, not a results release. According to the deck, QCi develops and commercializes products built on quantum and photonics technologies. It says it has more than 300 employees in 11 locations and customers worldwide. The company names its competitive advantages as proprietary room-temperature quantum photonics, vertical integration and scalable manufacturing. Its headline financial claim is $1.3 billion in cash and investments and no debt. The deck carries the usual warning that its forward-looking statements are not guarantees and that actual results may differ materially.

A balance sheet looking for a business

Follow the money and the first leg is easy. The cash is already in hand. The deck states that the balance sheet is there to fund the company’s quantum roadmap and the expansion of its commercial business.

The second leg, from the bank account into the business, is described in engineering terms. The presentation lists as key enablers a TFLN foundry with 3D integration, advanced packaging, quantum optics and nanophotonics expertise, scalable production on 200mm and 300mm wafers, and an in-house hardware facility. The output is meant to be quantum PICs, components and subsystems, integrated and packaged, across a portfolio QCi labels compute, capture and communicate. Over all of this sits the company’s stated vision: “Quantum Technology for Everyone, Everyday.”

The third leg, money flowing back in from customers, is where the portion of the deck reviewed by GSN goes quiet. It names no revenue figure. It gives no size for the commercial backlog, and it does not say how the cash will be split between research and the sales operation. The deck lists “growth of commercial backlog” and “operating cash flow generation” among the milestones the company anticipates. To our eye, that is a fair admission that both are still ahead of it.

For scale, take the company’s own market data. It puts QCi’s market capitalization at $1.9 billion. Against $1.3 billion of cash and investments, roughly two thirds of the company’s stock market value is money already in hand. The rest is what the market is paying for the technology, the foundry and the hope.

There is a second yardstick in the deck itself. It cites Boston Consulting Group estimating quantum industry revenue of $2.5 billion to more than $10 billion by 2030. QCi’s cash alone is about half the low end of that range for an entire industry. A company is rarely this well funded relative to the market it hopes to sell into.

What this could become

One possibility is that the factory becomes the story. If the TFLN foundry and wafer-scale production find buyers, QCi could look more like a specialty photonics supplier than a quantum computing company, with quantum as a long-dated option on top. The deck’s emphasis on manufacturing over machines leaves that door open.

A second possibility is the patient one. If commercial orders build slowly, the cash becomes runway, and what matters is how fast the roadmap burns through it. Having no debt means no lender sets the clock. That is a real advantage, though it does not stop the clock.

A third possibility depends on the forecasters. The deck leans on outside estimates, and they are far apart: BCG’s figure for 2030 and McKinsey’s $60 billion to $100 billion for 2035 are wide ranges from serious firms. If the industry tracks the lower numbers, the balance sheet could end up mattering more than the roadmap.

The signpost for all three is the same, and the company chose it: a disclosed backlog number, and the first quarter of positive operating cash flow.

The desk’s view

This desk admires the absence of debt and the plain listing of cash flow as a goal not yet reached. A company that names its own unfinished business deserves some credit for it. We are less taken with the investment highlights slide. It cites McKinsey’s estimate that quantum technology could create up to $2.7 trillion in economic value globally by 2035. Economic value created across whole industries is not revenue booked by a maker of components and subsystems, and the deck’s own revenue estimates sit orders of magnitude lower. Big numbers belong at the back of a pitch, not the front.

Think about the incentives on the other side of the table. A buyer of quantum or photonic components is betting that its supplier will still be around in five years, and a fat, debt-free balance sheet is a strong sales tool in that conversation. The deck makes no such argument, but this desk’s reading is that the cash may be doing commercial work as well as funding research. The questions we would put to management are simple. What does the commercial business bring in today? How large is the backlog? How much cash does a year of the roadmap consume?

What to watch

  • Any figure for commercial backlog, which the company lists as an anticipated milestone.
  • The first report of positive operating cash flow, also on the company’s own milestone list.
  • Progress on the TFLN foundry and the 200mm and 300mm scalable production described in the deck.
  • The risk factors in QCi’s annual report on Form 10-K, which the presentation points readers to.

The documents give no date for the next moment money changes hands. To our eye, the meaningful one is the first customer contract large enough to show up as backlog.

The cash to build is already in hand; now the company has to find customers who will pay for what it makes.

Sources